Blocking Toxic Protein Production In ALS
An FDA approved drug that blocks an integrated stress response is showing promise during preliminary testing against ALS and frontotemporal dementia, as published in EMBO Molecular Medicine. Those with ALS often have a string of repeated DNA codes within their brain cells which carry thousands of copies within the C9orf72 gene. Investigating what triggers these …